Drug Shortage Report for TEVA-QUININE
Report ID | 162864 |
Drug Identification Number | 00021016 |
Brand name | TEVA-QUININE |
Common or Proper name | TEVA-QUININE 300MG |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | QUININE SULFATE |
Strength(s) | 300MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | P01BC |
ATC description | ANTIMALARIALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-06-16 |
Estimated end date | 2022-12-20 |
Actual end date | 2022-12-07 |
Shortage status | Resolved |
Updated date | 2022-12-08 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v17 | 2022-12-08 | French | Compare |
v16 | 2022-12-08 | English | Compare |
v15 | 2022-12-01 | French | Compare |
v14 | 2022-12-01 | English | Compare |
v13 | 2022-09-30 | French | Compare |
v12 | 2022-09-30 | English | Compare |
v11 | 2022-09-22 | French | Compare |
v10 | 2022-09-22 | English | Compare |
v9 | 2022-09-07 | French | Compare |
v8 | 2022-09-07 | English | Compare |
v7 | 2022-08-18 | French | Compare |
v6 | 2022-08-18 | English | Compare |
v5 | 2022-06-30 | French | Compare |
v4 | 2022-06-30 | English | Compare |
v3 | 2022-06-17 | English | Compare |
v2 | 2022-06-16 | French | Compare |
v1 | 2022-06-16 | English | Compare |
Showing 1 to 17 of 17